Showing results (11-20 of 166) with videos related to

Sort By:
Pageof 17
Reumatismo|September 27, 2003
[Drug-induced lupus erythematosus]F Atzeni, M G Marrazza, P Sarzi-Puttini, et al.
Lupus|October 13, 2005
Cardiac imaging techniques in systemic autoimmune diseasesM Turiel, R Peretti, P Sarzi-Puttini, et al.
Reumatismo|June 19, 2014
Physiopathology of pain in rheumatologyM Cazzola, F Atzeni, L Boccassini, et al.
Lupus|October 13, 2005
Tumor necrosis factor-alpha, biologic agents and cardiovascular riskP Sarzi-Puttini, F Atzeni, A Doria, et al.
Reumatismo|September 10, 2016
Possible relationship between certolizumab pegol and arrhythmias: report of two casesR Talotta, F Atzeni, A Batticciotto, et al.
Clinical and Experimental Rheumatology|January 27, 2004
Successful treatment of pure red cell aplasia in systemic lupus erythematosus with cyclosporin AF Atzeni, P Sarzi-Puttini, F Capsoni, et al.
Annals of the Rheumatic Diseases|August 5, 2005
Anti-TNF antibody treatment improves glucocorticoid induced insulin-like growth factor 1 (IGF1) resistance without influencing myoglobin and IGF1 binding proteins 1 and 3P Sarzi-Puttini, F Atzeni, J Schölmerich, et al.
International Journal of Immunopathology and Pharmacology|April 19, 2011
Efficacy and safety of leflunomide or methotrexate plus subcutaneous tumour necrosis factor-alpha blocking agents in rheumatoid arthritisM Benucci, G Saviola, P Baiardi, et al.
Lupus|October 13, 2005
Behçet's disease and cardiovascular involvementF Atzeni, P Sarzi-Puttini, A Doria, et al.
Clinical and Experimental Rheumatology|December 24, 2010
Which kind of exercise is best in fibromyalgia therapeutic programmes? A practical reviewM Cazzola, F Atzeni, F Salaffi, et al.
Pageof 17